INOVIO to Present at the Oppenheimer 33rd Annual Healthcare Conference
INOVIO (NASDAQ: INO), a biotechnology firm focused on DNA medicines for HPV-related diseases, cancer, and infectious diseases, announced that Jacqueline Shea, Ph.D., CEO, will present at the Oppenheimer 33rd Annual Healthcare Conference on March 13, 2023, at 10:40 AM ET.
Dr. Shea and the management team will engage in one-on-one meetings with investors. A webcast of the presentation will be available on the INOVIO Investor Relations Events page, with a replay accessible for 90 days post-event. INOVIO's innovative approach includes using the CELLECTRA® device to generate immune responses against targeted health threats.
- None.
- None.
Oppenheimer 33rd Annual Healthcare Conference
Date:
Time:
Format: Fireside Chat
During the conference,
A webcast of the presentation will be available on the INOVIO Investor Relations Events page at https://ir.inovio.com/events-and-presentations/default.aspx. A replay of the webcast will be available for 90 days after the date of the presentation.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's DNA medicines in development are delivered using its investigational proprietary smart device, CELLECTRA®, to produce immune responses against targeted pathogens and cancers. For more information, visit www.inovio.com.
Contacts
Media:
Investors:
View original content:https://www.prnewswire.com/news-releases/inovio-to-present-at-the-oppenheimer-33rd-annual-healthcare-conference-301761773.html
SOURCE
FAQ
When is INOVIO's presentation at the Oppenheimer 33rd Annual Healthcare Conference?
Who will represent INOVIO at the Oppenheimer Conference?
Will there be a webcast for INOVIO's presentation?
How long will the webcast of INOVIO's presentation be available?
What is INOVIO's focus in biotechnology?
